India’s Serum Institute is seeking emergency authorisation in the European Union for its Covishield jab, sources told the BBC.
The move comes amid reports that Covishield is not yet eligible for the digital green certificate, an EU-wide travel pass, set to launch on 1 July.
The certificate is currently for EU citizens only.
Covishield is the Indian-made version of AstraZeneca’s Vaxzevria jab, which has been authorised in the EU.
It’s manufactured in India by Serum, the world’s largest vaccine maker.
The vaccines currently eligible for the green pass have all been approved by the European Medicines Agency (EMA).
Taiwan National Day Celebration
